Effects of switching from olanzapine, quetiapine, and risperidone to aripiprazole on 10-year coronary heart disease risk and metabolic syndrome status: results from a randomized controlled trial (Q36756154)
Jump to navigation
Jump to search
scientific article published on 21 February 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Effects of switching from olanzapine, quetiapine, and risperidone to aripiprazole on 10-year coronary heart disease risk and metabolic syndrome status: results from a randomized controlled trial |
scientific article published on 21 February 2013 |
Statements
1 reference
Effects of switching from olanzapine, quetiapine, and risperidone to aripiprazole on 10-year coronary heart disease risk and metabolic syndrome status: results from a randomized controlled trial (English)
1 reference
Henry A Nasrallah
1 reference
T Scott Stroup
1 reference
Matthew J Byerly
1 reference
Neepa Ray
1 reference
Ahsan Y Khan
1 reference
J Steven Lamberti
1 reference
Ira D Glick
1 reference
Richard M Steinbook
1 reference
Joseph P McEvoy
1 reference
Robert M Hamer
1 reference
21 February 2013
1 reference
1 reference
190-195
1 reference
2 references
Identifiers
1 reference
1 reference
1 reference